These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 26321107

  • 21. High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.
    Barr ELM, Barzi F, Hughes JT, Jerums G, Hoy WE, O'Dea K, Jones GRD, Lawton PD, Brown ADH, Thomas M, Ekinci EI, Sinha A, Cass A, MacIsaac RJ, Maple-Brown LJ.
    Diabetes Care; 2018 Apr; 41(4):739-747. PubMed ID: 29367427
    [Abstract] [Full Text] [Related]

  • 22. Serum uric acid to creatinine ratio: A predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function.
    Gu L, Huang L, Wu H, Lou Q, Bian R.
    Diab Vasc Dis Res; 2017 May; 14(3):221-225. PubMed ID: 28183204
    [Abstract] [Full Text] [Related]

  • 23. Rate of kidney function decline and factors predicting progression of kidney disease in type 2 diabetes mellitus patients with reduced kidney function: A nationwide retrospective cohort study.
    Kaewput W, Thongprayoon C, Chewcharat A, Rangsin R, Satirapoj B, Kaewput C, Suwannahitatorn P, Bathini T, Mao MA, Cato LD, Harrison AM, Vaitla P, Cheungpasitporn W.
    Ther Apher Dial; 2020 Dec; 24(6):677-687. PubMed ID: 31997551
    [Abstract] [Full Text] [Related]

  • 24. Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus.
    Mohsen A, Brown R, Hoefield R, Kalra PA, O'Donoghue D, Middleton R, New D.
    J Nephrol; 2012 Dec; 25(3):384-93. PubMed ID: 22241634
    [Abstract] [Full Text] [Related]

  • 25. Risk Prediction for Early CKD in Type 2 Diabetes.
    Dunkler D, Gao P, Lee SF, Heinze G, Clase CM, Tobe S, Teo KK, Gerstein H, Mann JF, Oberbauer R, ONTARGET and ORIGIN Investigators.
    Clin J Am Soc Nephrol; 2015 Aug 07; 10(8):1371-9. PubMed ID: 26175542
    [Abstract] [Full Text] [Related]

  • 26. Association of advanced glycation end products and chronic kidney disease with macroangiopathy in type 2 diabetes.
    Rigalleau V, Cougnard-Gregoire A, Nov S, Gonzalez C, Maury E, Lorrain S, Gin H, Barberger-Gateau P.
    J Diabetes Complications; 2015 Mar 07; 29(2):270-4. PubMed ID: 25468311
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of cystatin C- and creatinine-based estimation of glomerular filtration rate according to glycaemic status in Type 2 diabetes.
    Oh SJ, Lee JI, Ha WC, Jeong SH, Yim HW, Son HS, Sohn TS.
    Diabet Med; 2012 Jul 07; 29(7):e121-5. PubMed ID: 22414167
    [Abstract] [Full Text] [Related]

  • 29. Carbamylated Lipoproteins and Progression of Diabetic Kidney Disease.
    Tan KCB, Cheung CL, Lee ACH, Lam JKY, Wong Y, Shiu SWM.
    Clin J Am Soc Nephrol; 2020 Mar 06; 15(3):359-366. PubMed ID: 32075807
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. One-year treatment with liraglutide improved renal function in patients with type 2 diabetes: a pilot prospective study.
    Zavattaro M, Caputo M, Samà MT, Mele C, Chasseur L, Marzullo P, Pagano L, Mauri MG, Ponziani MC, Aimaretti G, Prodam F.
    Endocrine; 2015 Dec 06; 50(3):620-6. PubMed ID: 25572181
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease.
    Yale JF, Bakris G, Cariou B, Nieto J, David-Neto E, Yue D, Wajs E, Figueroa K, Jiang J, Law G, Usiskin K, Meininger G, DIA3004 Study Group.
    Diabetes Obes Metab; 2014 Oct 06; 16(10):1016-27. PubMed ID: 24965700
    [Abstract] [Full Text] [Related]

  • 33. Association between copeptin and declining glomerular filtration rate in people with newly diagnosed diabetes. The Skaraborg Diabetes Register.
    Pikkemaat M, Melander O, Bengtsson Boström K.
    J Diabetes Complications; 2015 Oct 06; 29(8):1062-5. PubMed ID: 26321369
    [Abstract] [Full Text] [Related]

  • 34. The association between endostatin and kidney disease and mortality in patients with type 2 diabetes.
    Carlsson AC, Östgren CJ, Länne T, Larsson A, Nystrom FH, Ärnlöv J.
    Diabetes Metab; 2016 Nov 06; 42(5):351-357. PubMed ID: 27080454
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
    Kim SS, Song SH, Kim IJ, Lee EY, Lee SM, Chung CH, Kwak IS, Lee EK, Kim YK.
    J Diabetes Complications; 2016 Jul 06; 30(5):887-92. PubMed ID: 27037042
    [Abstract] [Full Text] [Related]

  • 39. Development and validation of a predictive model for Chronic Kidney Disease progression in Type 2 Diabetes Mellitus based on a 13-year study in Singapore.
    Low S, Lim SC, Zhang X, Zhou S, Yeoh LY, Liu YL, Tavintharan S, Sum CF.
    Diabetes Res Clin Pract; 2017 Jan 06; 123():49-54. PubMed ID: 27923172
    [Abstract] [Full Text] [Related]

  • 40. Circulating fibroblast growth factor 21 levels predict progressive kidney disease in subjects with type 2 diabetes and normoalbuminuria.
    Lee CH, Hui EY, Woo YC, Yeung CY, Chow WS, Yuen MM, Fong CH, Xu A, Lam KS.
    J Clin Endocrinol Metab; 2015 Apr 06; 100(4):1368-75. PubMed ID: 25625802
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.